Insmed INSM
$141.33 −$3.13 (-2.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $142.81 +1.05%
Open$143.27
Prev close$144.46
Day range$140.99 – $150.00
Volume6.22M
Market cap$31.01B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts16
Average target$191.07+35.2% vs. price
- Buy 94%
- Hold 6%
Low $158.00Now $141.33Avg $191.07High $220.00
Recent rating changes
The last 20 actions on file set price targets from $154.00 to $220.00, averaging $192.05.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 20 Nov 2026 | BofA Securities | BUY | $205.00 |
| 19 Nov 2026 | Mizuho Securities | BUY | $158.00 |
| 19 Nov 2026 | Raymond James | BUY | – |
| 19 Nov 2026 | BofA Securities | BUY | $205.00 |
| 19 Nov 2026 | Guggenheim | BUY | $201.00 |
| 17 Nov 2026 | RBC Capital | BUY | $195.00 |
| 13 Nov 2026 | Morgan Stanley | BUY | $213.00 |
| 5 Nov 2026 | Evercore | BUY | $170.00 |
| 4 Nov 2026 | H.C. Wainwright | BUY | $220.00 |
| 3 Nov 2026 | Mizuho Securities | BUY | $158.00 |
| 2 Nov 2026 | BMO Capital | BUY | $192.00 |
| 2 Nov 2026 | Barclays | BUY | $207.00 |
| 1 Nov 2026 | Guggenheim | BUY | $201.00 |
| 30 Oct 2026 | UBS | BUY | $172.00 |
| 30 Oct 2026 | Morgan Stanley | BUY | $213.00 |
| 30 Oct 2026 | BMO Capital | BUY | $192.00 |
| 30 Oct 2026 | Goldman Sachs | BUY | $194.00 |
| 29 Oct 2026 | Mizuho Securities | BUY | $154.00 |
| 29 Oct 2026 | Roth MKM | BUY | $204.00 |
| 29 Oct 2026 | RBC Capital | BUY | $195.00 |
No comments yet — be the first to weigh in on INSM.
Sign in to join the discussion.